Human CellExp™ TROP-2 / TACSTD2, Human recombinant

(No reviews yet) Write a Review
Usually Shipped in 5 Working Days
Storage Temperature:
Shipping Conditions:
Gel Pack
Shelf Life:
12 months
€142.00 - €438.00
Frequently bought together:


Biomolecule/Target: TACSTD2

Synonyms: TACSTD2, GA733-1, M1S1, TROP2

Alternates names: TACSTD2, GA733-1, M1S1, TROP2

Taglines: A cell surface glycoprotein function as a growth factor receptor.

Taglines: USA

Country of Animal Origin: USA

NCBI Gene ID #.: 4070

NCBI Gene Symbol: TACSTD2

Gene Source: Human

Accession #: P09758

Recombinant: Yes

Source: HEK 293 cells

Purity by SDS-PAGE #: > 90%


Purity: N/A

Assay #2: N/A

Endotoxin Level: < 1.0 EU per/μg

Activity (Specifications/test method): N/A

Biological activity: N/A

Results: N/A

Binding Capacity: N/A

Unit Definition: N/A

Molecular Weight: rh TACSTD2 /TROP2, fused with polyhistidine tag at the Cterminus. The predicted N-terminus is Thr 88.

Concentration: N/A

Appearance: Lyophilized

Physical form description: Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4.

Reconstitution Instructions: Reconstitute in sterile deionized water to the desired protein concentration.

Background Information: Tumor-associated calcium signal transducer 2 (TACSTD2) is also known as Cell surface glycoprotein Trop-2, Membrane component chromosome 1 surface marker 1 (M1S1), Pancreatic carcinoma marker protein GA733-1, which belongs to the EPCAM family. TACSTD2 contains one thyroglobulin type-1 domain. TACSTD2 is a carcinoma-associated antigen defined by the monoclonal antibody GA733. TACSTD2 transduces an intracellular calcium signal and acts as a cell surface receptor. Mutations of TACSTD2 result in gelatinous drop-like corneal dystrophy, an autosomal recessive disorder characterized by severe corneal amyloidosis leading to blindness

Amino acid sequence: N/A

Handling: Centrifuge the vial prior to opening.

Usage: For Research Use Only! Not to be used in humans

View AllClose